The Scientist

» drug discovery

Most Recent

image: Antibiotic Bouncer

Antibiotic Bouncer

By | March 1, 2013

Contrary to previous assumptions that macrolide antibiotics completely block the exit tunnel of ribosomes, new evidence shows that some peptides are allowed to pass.

0 Comments

image: Teenage Drug Hunter

Teenage Drug Hunter

By | March 1, 2013

An Oregon teenager spent a summer in a New York biochemistry lab helping to discover a novel molecule that could become the next commercial nonaddictive painkiller.

0 Comments

image: Is Frog Skin a Red Herring?

Is Frog Skin a Red Herring?

By | January 2, 2013

Despite decades of work, compounds in frog skins have failed to yield new antibiotics. Why?

2 Comments

image: Opinion: Parachuting off the Patent Cliff

Opinion: Parachuting off the Patent Cliff

By | December 6, 2012

As the United States edges ever closer to the dreaded fiscal cliff, the pharmaceutical industry approaches a precipice of its own.

4 Comments

image: Neil Bence: Manipulating Degradation

Neil Bence: Manipulating Degradation

By | December 1, 2012

Senior Scientist, Millennium Pharmaceuticals: The Takeda Oncology Company Age: 39

0 Comments

image: Tumor Snipers

Tumor Snipers

By | November 1, 2012

After two headline successes, companies rush to develop “smart bomb” cancer drugs.

0 Comments

image: Next Generation: The Heart Camera

Next Generation: The Heart Camera

By | June 19, 2012

A new camera system allows researchers to measure multiple cardiac signals at once to understand how they interact to control heart function.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham